Epithelial organoids are now an important tool in fields ranging from regenerative medicine to 9 drug discovery. Organoid culture requires Matrigel, a complex, tumor-derived, extracellular 10 matrix. An alternative completely synthetic matrix could improve culture reproducibility, clarify 11 mechanistic phenomena, and enable applications involving human implantation. Here, we 12 designed synthetic matrices with tunable biomolecular and biophysical properties that allowed us 13 to identify critical gel parameters in organoid formation. Inspired by known epithelial integrin 14 expression in the proliferative niche of the human intestine, we identified an a2b1 integrin-binding 15 peptide as a critical component of the synthetic matrix that supports human duodenal colon and 16 endometrial organoid propagation. We show that organoids emerge from single cells, retain their 17 proliferative capacity, are functionally responsive to basolateral stimulation and have correct 18 apicobasal polarity upon induction of differentiation. The local biophysical presentation of the 19 cues, rather than bulk mechanical properties, appears to be the dominant parameter governing 20 epithelial cell proliferation and organoid formation in the synthetic matrix. 21 . 22
Introduction 23
Epithelial organoids are three-dimensional (3D) structures with microarchitecture, cellular 24 composition and functions, similar to their native tissues 1 . They are used to model tissue 25 homeostasis and pathophysiological processes and as in vitro models for drug development 1-3 . 26 However, their full potential has been hindered by the requirement for propagation in Matrigel, a 27 complex, tumor-derived extracellular matrix (ECM) containing a plethora of growth factors (GFs) 28 that are variable from lot-to-lot and exert unknown effects on organoid phenotype 4-7 . Envisioned 29 applications involving re-implantation of patient-derived organoids require Good Manufacturing 30 Practices (GMP) that exclude tumor-derived material 8, 9 . Hence, there are many forces driving the 31 development of synthetic matrices in which all exogenous biological cues are known and defined. 32 Towards this goal, Gjorevski et al., developed a synthetic poly(ethylene) glycol (PEG) gel 1 modified with a fibronectin (FN)-derived RGD peptide or laminin (LMN)-derived peptides that 2 supported mouse intestinal organoid growth but not differentiation. Differentiation was achieved 3 in a semisynthetic matrix made with PEG and full-length LMN 10 . Human organoids survived in 4 the PEG-RGD gel, although expansion, differentiation, and other features were not reported. 5
Mouse organoid growth in the PEG gel appear to depend on the gel's bulk mechanical properties: 6 stiff (~1.3 kPa) for organoid formation and soft (~300 Pa) for differentiation 10 . The gel's bulk 7 mechanical properties were modulated by processes that simultaneously also affect other gel 8
properties, such as ligand accessibility, clustering, and nanomechanical responses to cell-generated 9 forces after ligand binding [11] [12] [13] [14] [15] [16] [17] [18] [19] . The observation that organoids grow significantly better in 10 Matrigel or in hydrogels made with low concentrations of purified LMN than in PEG-RGD or 11 collagen gels 10,20-23 suggests that specific cell-matrix affinity interactions might play a critical role 12 in organoid formation and differentiation. Untangling the relative contributions of bulk mechanical 13
properties from other gel biophysical and biomolecular properties on cell proliferation and 14 organoid formation is challenging. 15
Inspired by integrins expression in the native tissue, here we create synthetic matrices with 16 tunable biophysical and biomolecular properties that support organoid formation and 17 differentiation across multiple donors and tissue types. The local biophysical presentation and the 18 identity of the integrin-binding motif, rather than bulk biomechanical properties or matrix 19 degradation, appear to be the dominant variables governing epithelial cell proliferation and 20 organoid formation in the synthetic matrix. 21 22
Niche-inspired synthetic ECM 23
Intestinal stem cells (ISCs) at the bottom of the crypt express a2b1 and a5b1 integrins 24-29 . 24 Consequently, ligands for these receptors are attractive components of synthetic ECM. We created 25 a modular synthetic ECM by combining 8-arm vinyl sulfone-activated PEG macromers partially 26 modified with integrin-binding peptides and matrix-binding peptides together with peptide 27 crosslinkers containing a matrix-metalloproteinase (MMP)-sensitive degradation site. In our 28 design, we focused on three variables that influence integrin-ligand interactions: a) identity of the 29 integrin-binding ligand b) biophysical properties of ligand presentation and c) matrix 30 biomechanical properties at local and macroscale (Fig 1a) . We also included cell-mediated matrix 31 remodeling (via proteases and matrix deposition) and dynamic softening, via Sortase degradation, 1 as additional variables. 2
As PEG chains are highly flexible in aqueous solution, they can be tailored in length to 3 modulate ligand accessibility [11] [12] [13] [14] [15] [16] [17] [18] [19] and in combination with crosslinking density, also modulate 4 local and bulk mechanical properties [30] [31] [32] . In our design, the arm PEG lengths were modulated to 5 either ~20 nm or ~40 nm (when fully extended from the central polymer core) by using 8-arm PEG 6 macromers of 20kDa or 40kDa, respectively (Fig 1a) . To parse the role of the a2b1 and a5b1 7 integrins on cell survival and organoid formation, we created matrices using single, or mixed (1:1, 8 w/v) macromers with a fixed crosslinking density. To engage the a5b1 integrin, we functionalized 9 the PEG macromers with an FN-derived peptide that contains the RGD motif and the PHSRN 10 synergy site (PEG-PHSRN-K-RGD) 11, 33, 34 . Likewise, to engage the a2b1 integrin, we used a 11 collagen I-derived peptide harboring the GFOGER sequence (PEG-GFOGER) 35 . 12 We also considered that initial integrin engagement is only a first step, with possible subsequent 13 interactions mediated by matrix that cells produce and assemble locally 36, 37 . Hence, we included 14 peptides with affinity for FN, collagen IV (C-IV), and LMN (FN-binder and BM-binder, 15 respectively) [38] [39] [40] [41] . Lastly, we considered that organoid growth might require matrix degradation, 16 thus we used a protease-sensitive crosslinker concatenated with a site susceptible to cleavage with 17 exogenously-added transpeptidase SrtA enzyme to enable cell-mediated matrix remodeling and 18 recovery of intact organoids, respectively 38 . 19
Six synthetic matrix formulations (40kDa-PHSRN-K-RGD, 40kDa-GFOGER, 20kDa-20 PHSRN-K-RGD, 20kDa-GFOGER, 40/20kDa-PHSRN-K-RGD, 40/20kDa-GFOGER) that 21 varied in bulk mechanical properties but contained similar crosslinker density and equal nominal 22 concentration of integrin-, BM-and FN-binding peptides, were made. In the PEG-PHSRN-K-23 RGD matrices, the RGD and PHSRN sites are presented in a branched configuration to mimic the 24 biophysical presentation found in native FN 11,42 whereas in the PEG-GFOGER, three cell-binding 25 cues are presented as a triple helix, thus mimicking the biophysical presentation of collagen fibers 26 synthetic matrices, we selected seven human donors (six duodenal and one colon) that varied in 2 sex, age and pathological state, and one mouse colon donor. Dissociated single cells were 3 embedded in the synthetic matrices and then cultured in expansion medium (EM). To facilitate the 4 identification of a suitable matrix for organoid culture, we used the organoid diameter as a proxy 5 for cell proliferation and organoid growth (Extended Data Fig 1) 45 . 6
Overall, organoids emerging in both Matrigel and in the synthetic matrices had a wide range 7 of size distributions, but all were spherical with a single layer of thin epithelial cells. We considered 8 this phenotype as undifferentiated and potentially stem-enriched organoids ( . We designated these spherical organoids as "enteroids" and reserved the term "organoid" 10 for enteroids that underwent differentiation and adopted a thick columnar epithelial cell layer. 11
The synthetic matrices supported enteroid formation from human and mouse donors with 12 various degree of success (Fig 1b,d , Extended Data Fig 2) . Compared to Matrigel, human enteroids 13 in the synthetic matrices were smaller. Interestingly, human colon enteroids grew slower, in 14
Matrigel and the synthetic matrices, compared to the duodenal enteroids. In contrast, mouse colon 15 enteroids grew faster than human colon enteroids in Matrigel or the synthetic matrices. In some 16 matrix conditions mouse colon enteroids reached sizes similar to mouse colon enteroids in 17 Matrigel, ( Extended Data Fig 2b) . 18
From the two sets of synthetic matrices, the PEG-GFOGER (a2b1) series supported enteroid 19 formation, across all donors, to a greater extent than the PEG-PHSRN-K-RGD (a5b1) series, even 20 though the encapsulated cells expressed a2, a5, and b1 integrins (Extended Data Fig 3a) . The 21 ability of the PEG-GFOGER series to support enteroid formation is not due to bulk mechanical 22 differences, as the 20kDa-PHSRN-K-RGD and the 20kDa-GFOGER matrices have similar 23 mechanical properties, yet we observed significant differences in enteroid diameters (Fig 1c- 
d, 24
Extended Data Fig 2) . We also noted that the GFOGER bioactivity is context dependent, as 25 matrices with relatively high swelling, lower storage modulus, and longer PEG arms, failed to 26 promote robust enteroid formation (Compare 40kDa-GFOGER vs 20kDa-GFOGER). Matrices 27 made with the 1:1 (w/v) mixed macromers (40/20kDa-GFOGER) rescued the GFOGER 28 bioactivity. This is more likely because ~70% of PEG arms in the 40/20kDa-GFOGER matrix 29 correspond to the 20kDa-PEG macromer, which results in a matrix of similar biomechanical 30 properties as the 20kDa-GFOGER (Fig 1b-d) . This phenomenon of context-dependent success of 31 enteroid formation was not observed in the PEG-PHSRN-K-RGD series, in part because enteroid 1 emergence was relatively poor. 2 Collectively, the data shows that intestinal cell proliferation and enteroid formation occurs in a 3 narrow set of matrix mechanical properties in human enteroids and in a broader range in mouse 4 enteroids. Notably, our results highlight the significance of using a variety of donors and tissue 5 types, as matrices that supported mouse enteroids failed with human donors. Across the human 6 donors, we also noticed donor-to-donor variability on enteroid diameter and size distribution in 7 the synthetic matrices that mirrored the donor-to-donor variability observed in Matrigel. Compared 8 to Matrigel, the synthetic ECM supported enteroid formation efficiency of 47% (duodenal) and 9 40% (colon) (Fig 1e) . These differences could be due to the number of residual growth factors and 10 cytokines in Matrigel that are absent in our synthetic ECM. 11
12

Enteroid growth depends on GFOGER/a2b1 13
Modulation of the ligand's properties in the 20kDa-GFOGER matrix revealed that enteroid 14 formation depends on the a2b1 integrin binding to the GFOGER peptide (Fig 2a) in a dose-15 dependent manner (Fig 2b-c ). An inactive form of the GFOGER peptide (GFOGDR) 35 caused an 16 increase in the number of dead cells and failed to promote enteroid formation (Fig 2a and c) . Thus, 17 engaging a2b1 is not only essential for enteroid formation but also needed to maintain a population 18 of cells that do not form enteroids, yet remain viable. 19
Changes in the identity and concentration of the crosslinker also affected enteroid formation. 20
Enteroids emerged from single cells encapsulated in a non-degradable synthetic ECM, but by 6 21 days were smaller and less abundant compared to enteroids in matrices made with a cell-22 degradable crosslinker (Extended Data Fig 3b) . This suggests that the matrix's microarchitecture 23 can support initial cell proliferation to establish enteroids, but later stages in growth might require 24 simultaneous matrix degradation. Crosslinker densities of 45 and 50% at 1.5 mM nominal 25 concentration of GFOGER appears the most favorable environment for enteroid growth. Lower 26 crosslinker densities caused greater hydrogel swelling and reduced enteroid growth, possible due 27 to changes in ligand distribution combined with a dilution effect of the GFOGER concentration 28 within the matrix (Extended Data Fig 3c) . 29
Because ligand presentation and clustering affect integrin binding, we wondered if the higher 30 GFOGER bioactivity compared to PHSRN-K-RGDS was due to the triple-helical nature of the 31 peptide that extends and clusters the ligand away from the PEG polymer core compared to the 1 branched and shorter configuration of the PHSRN-K-RGDS. Longer and clustered integrin 2 binding peptides have been shown to increase accessibility and integrin binding which results in 3 higher cell proliferation [46] [47] [48] . Thus, we hypothesized that increasing the a5b1 ligand accessibility 4 and clustering, while maintaining the bulk mechanical properties constant, would result in 5 increased enteroid formation. We synthesized three peptides harboring the a5b1 ligand (Arg-Gly-6
Asp,Ser, RGDS); a short linear peptide (RGDS), a longer extended ligand (G11RGDS) and a 7 longer and clustered RGDS ligand (CMPRGDS) 47 (Fig 2d-e ). Although we saw an increase in 8 enteroid formation efficiency and diameters with the extended (G11RGDS) and clustered 9 (CMPRGDS) peptides compared to linear RGDS, they were significantly smaller were less 10 efficient in enteroid formation than the GFOGER matrix (Fig 2f-g) . 11
Collectively, the previous data point to a mechanism for enteroid formation that appears to be 12 dependent on the GFOGER-a2b1 integrin interaction, as extending and clustering the a5b1 13 (RGDS) ligand failed to promote robust enteroid growth. Further, GFOGER presentation appears 14 to be favored by shorter (~20 nm) compared to longer (~40 nm) PEG arms, possibly due to a 15 favorable nanomechanical response when the cells pull on the ligand 11, 13, 17, 19 . 16 17
Enteroid characterization in the synthetic ECM 18
To gain more insight into the growth of human enteroids in the synthetic ECM, we followed the 19 formation of enteroids from single cells ( by day four in the synthetic ECM (Fig 3a) . By day six, cells that failed to form enteroids were still 23 viable (Fig 3b) . Viable single cells that did not form enteroids were observed in various human 24 donors (Extended Data Fig 4b) . Time-lapse live cell imaging from day 4 to 6 revealed that 25 enteroids in Matrigel and the synthetic ECM grew in a manner reminiscent of fluid pressure 26 oscillations 49,50 . Time-lapse live cell imaging also captured epithelial cells being extruded into the 27 lumen in Matrigel and the synthetic ECM, suggesting the establishment of a functional and 28 polarized epithelial layer (see red arrows in Fig 3d and supplementary videos) . Actin staining 29 further confirmed correct enteroid polarization across multiple donors (Extended Data Fig 4c) . 30
As enteroids in the synthetic ECM, on average, had a delayed growth, we extended our 1 organoid diameter analysis for up to ten days. Although enteroids in the synthetic ECM continued 2 to grow (Fig 3b-c) , the size distribution of the overall population at day 10 did not reach that of 3 the population in Matrigel at day 6. Interestingly, enteroids in Matrigel at days 8 and 10 started to 4 fuse and created a mass of interconnected cells at the bottom of the well accompanied by 5 significant cell death, possibly due to Matrigel degradation and dissolution. We did not observe 6 such a phenomenon in the synthetic ECM, which is an important feature for long-term culture and 7 emerging application of organoids. 8
Properly polarized and functional organoids can be used to study adaptive epithelial 9 responses 51 . To test if enteroids in the synthetic ECM were functionally responsive to basolateral 10 stimulation, we treated six-day old enteroids with prostaglandin E2 (PGE2) and forskolin (FKL). 11 PGE2 and FKL have been shown to induce rapid morphological changes characterized by an 12 increase in organoid diameter 51,52 . Upon PGE2 and FKL treatment, enteroids in the synthetic ECM 13 increased in diameter, similar to the response we observed with enteroids in Matrigel (Extended 14 Data Fig 6d-e, Supplementary videos) . This response suggests that the synthetic ECM not only 15 supports functionally responsive enteroids but is also flexible enough to accommodate a rapid 16 increase in enteroid size that is more likely independent of matrix degradation. 17 18
Enteroids in the synthetic ECM retain their proliferative capacity 19
Epithelial organoids can be cultured continuously due to an undifferentiated stem cell population 20 that, when re-embedded in Matrigel, gives rise to new organoids 53 . To determine if a population 21 of undifferentiated and proliferative cells existed in enteroids emerging in the synthetic ECM, we 22 performed quantitative PCR (qPCR) for five genes associated with active stem cells, six genes 23 associated with quiescent stem cells (+4 position) and nine genes associated with progenitor cells 24 54,55 . Overall, in the two duodenal donors tested, we observed similar levels of gene expression of 25 active and quiescent stem and progenitor genes in enteroids emerging in the synthetic ECM 26 compared to Matrigel, except for SMOC2, MMP7, and ATOH1 genes that showed more 27 variability (Fig 4a and Extended Data Fig 5a) . 28
As enteroids in the synthetic matrix appear to retain a similar gene expression profile to 29 enteroids in Matrigel, we sought to investigate if they contained a proliferative cell population 30 capable of forming new enteroids when re-embedded in new synthetic ECM or Matrigel. Six-day 31 old enteroids were collected from the synthetic ECM and then processed (see Methods) to generate 1 single cells to re-embed into new synthetic ECM or Matrigel (Extended Data Fig 6a) . We 2 performed this procedure for three consecutive passages with two duodenal donors. Quantification 3 of the total number of cells recovered after each passage in the synthetic ECM revealed a 1.5 to 2-4 fold increase in cell expansion relative to the initial number of encapsulated cells (Extended Data 5 Fig 6b) . As described before, we also noted a population of cells that failed to form enteroids but 6 remained viable. This cell population was also included in the calculation of fold increase in 7
Extended Data Fig 6b. Interestingly, when single cells from organoids grown in the synthetic ECM 8 were embedded in Matrigel there was more than 14-fold increase in cell expansion as the majority 9 of single cells formed enteroids. This might be due to the number of residual growth factors present 10 in Matrigel that could induce a proliferative phenotype in otherwise quiescent cells 55,56 . This 11 observation furthers highlights the significance of developing a suitable matrix to uncover 12 biological processes in epithelial organoids masked when using ill-defined Matrigel hydrogels. 13
Quantification of enteroid diameters after each passage further revealed a wide range of sizes in 14 the population, but similar to previous results, enteroids in Matrigel were, on average, bigger than 15 those in the synthetic ECM ( LGR5 ligand, R-spondin1, in LGR5-positive ISCs 53 , or DM made with lower concentrations of L-31 WRN (Wnt3a, R-spondin1 and Noggin) conditioned medium (L-WRN-DM) 63 . Stem-enriched 1 mouse enteroids grown in a synthetic ECM, in contrast, undergo rapid cell death upon switching 2 to DM, due to a rapid loss of resident stem cells 10 . We hypothesized that to allow differentiation 3 in a synthetic ECM we would need to preserve a pool of stem cells while allowing the emergence 4 of differentiated cells. Thus, enteroids were differentiated using a lower concentration of L-WRN 5 conditioned medium. Human duodenal and colon enteroids were grown for six days in EM (50% were bigger and more abundant than organoids in the synthetic matrices. Nonetheless, from all the 30 synthetic matrices tested, the 20kDa-GFOGER (a2b1) supported bigger and more abundant 31 endometrial organoids (Fig 6a-b ). Endometrial organoids, in the synthetic ECM, showed 1 proliferative cells (EdU), epithelial (EpCAM) and apicobasal markers (actin, LMN) similar to 2 those grown in Matrigel (Fig 6c-d) . 3 4
Conclusions 5
Designing a synthetic matrix that supports robust organoid formation and differentiation from a 6 spectrum of different donor origins has been challenging due to differences between mouse and 7 human organoids along with donor-to-donor variability. We report for the first time, to our 8 knowledge, a fully synthetic matrix that support organoid formation from different tissue types 9 and epithelial organs. Inspired by integrin expression in the native tissue, we found that the local 10 biophysical presentation of an a2b1 integrin-binding peptide, rather than the bulk gel's mechanical 11
properties, appears to be the dominant variable governing epithelial cell proliferation and organoid 12 formation. We found that enteroids emerging in the synthetic ECM are, on average, less numerous 13 and showed delayed growth compared to Matrigel. This discrepancy could be attributed to: 14 residual GFs in Matrigel that affect organoid biology in unknown ways; additional matrix 15 components (e.g., laminins) that stimulate additional signaling pathways; the propensity of 16
Matrigel to bind GFs present in the culture media and serve as a depot for later release; or any 17 combination of these. Interestingly, single cells that do not progress to enteroids remain viable in 18 the synthetic ECM for over a week. Thus, the synthetic matrix may allow interrogation and 19 discovery of factors that impact organoid biology. 20
Although not fully explored here, the synthetic ECM offers additional benefits such as on-21 demand dissolution to recover intact cells and cell-secreted metabolites 38 and incorporation of 22 small peptide that sequester cell-secreted matrix for an in-depth investigation of cell-matrix 23 deposition in tissue formation 39 . We expect that these features will be of great utility to uncover 24 complex and dynamic cell-cell communications in emerging stromal-epithelial co-culture 25 systems 39 . We further envision that the synthetic matrix can also be used in microfabrication 26 approaches aimed to replicate the intestinal topography 62, 63 . Such systems would also require cues 27 to engage a2b1-expressing cells to preserve a proliferative compartment. In conclusion, the matrix 28 developed here has the potential to be a "one size fits all" to multiple applications. To facilitate its 29 adoption by the organoid and bioengineering community, we used commercially available and 30 made-to-order reagents that require minimal manipulation and common laboratory equipment. 31 added to the reaction mixture and allowed to react for an additional 30 min at RT. This sequential 30 reaction created a PEG-functionalized mixture ''fPEG-VS'' that was used to resuspend the cells 31 prior to matrix gelation (see cell encapsulation below). The nominal concentration of the matrix-1 binders in all matrices was 0.25 mM each, whereas the integrin binder peptides were at 1.5 mM 2 (unless otherwise noted in the figure legends). For most experiments the fPEG-VS solution was 3 crosslinked at 50% crosslinking density (unless otherwise noted in the figure legends). 4
Rheological characterization. After adding the XL-IA crosslinker (50%), 20 µL of each matrix 5 mixture was loaded into a 1 mL syringe that had the tip cut off at the 0.1 mL mark. The matrix 6 was allowed to gel at 37 ºC for 20 min and then moved to a 24 well plate that contained 400 µL of 7 1X PBS. The plate was incubated for 24 hours in a humidified incubator at 37 ºC, 95% air, and 8 5% CO2, to allow for equilibrium swelling to occur prior to rheological characterization. This 9 procedure created matrices discs of 1-1.4 mm in thickness. The discs were sandwiched between 10 an 8 mm sandblasted parallel plate and sandblasted base. The shear modulus was determined by 11 performing small-strain oscillatory shear measurements on an Anton Parr MCR 302 instrument. 12
The mechanical response was recorded by performing frequency sweep measurements (0.1-10 13 Hz) in a constant strain mode (0.05), at 37 °C. The shear modulus (G') is reported as a measure of 14 matrix mechanical properties. 15
Equilibrium swelling. The matrices were prepared at 50% crosslinking density (unless otherwise 16 noted in the figure legends) as described above. After adding the XL-VP crosslinker, three 30-µL 17 droplets were loaded onto three 18-mm circular glass micro-coverslips. 18
The mass of the coverslip (mCs) were determined prior to the addition of the gel mixture to 19 calculate the percentage of swelling (see below). The gel mixture/coverslips were placed inside of 20 a 12-well plate and allowed to gel for 20 min in a humidified incubator at 37 °C, 95% air, and 5% 21 CO2. At the end of the gelation, each coverslip was weighed again and the mass recorded as "pre-22 swelled matrix mass (mpSM)". One mL of 1X PBS was loaded onto each matrix droplet and 23 returned to the incubator for 24 hours to allow the matrix to reach equilibrium swelling. After 24 24 hours, the PBS was removed, and the matrices were washed twice with 1 mL of dH2O. The water 25 was removed completely before the matrix/coverslips were weighed again. This was recorded as 26 "swelled matrix mass (mSM)". Finally, the matrix/coverslips were placed in a 60 °C oven 27 overnight to determine the mass of the dry matrix. To calculate the percentage of swelling we sued 28 the following formula ((mpSM-mCs)/(mSM-mCs))*100. The pore size (x) was calculated 29 according to Flory-Rehner equations and derived formulas described previously 13 . In experiments 30 to determine the effect of the crosslinking density on swelling and pore size, the synthetic matrices 31 were made with 35, 40, 45, 50, 55, and 60% XL-VP crosslinker density. The percentage of swelling 1 and pore size were calculated as above. 2 Cell encapsulation. Four-day old organoids grown in Matrigel were collected and processed as 3 above to generate single cells. The cell suspension was inspected under the microscope to ensure 4 the presence of dispersed single cells and if needed, filtered through a 30 µm cell strainer to remove 5 cell clumps. Single cells were counted using a hemocytometer then resuspended in the matrix 6 precursor solutions (fPEG-VS) prior to the addition of the crosslinker and Y-27632 (10 µM). In 7 parallel, single cells were resuspended in Matrigel that served as experimental control during 8 matrix evaluation. In both cases, cells were encapsulated at a density of 500 cells/µL of matrix. 9
Three µL (1,500 cells) of the matrices were loaded into a Nunc MicroWell 96-well optical-Bottom 10 plate and allowed to polymerase for 20 min in a humidified incubator at 37 ºC, 95% air, and 5% 11 CO2. After gelation, 100 µL of EM or EnOM was loaded into each well. Media was changed every 12 two days. Eight-day old endometrial organoids were used to generate single cells. The 13 encapsulation process in Matrigel or the synthetic ECM, for endometrial organoids, was performed 14 similar to intestinal organoids. 15
Intestinal and endometrial enteroid/organoid diameter. The diameter of six-day old enteroids 16 and eight-day old endometrial organoids were determined using a deep learning based algorithm 17 as described previously 14 . 4X brightfield (BF) images were captured using an EVOS M500 18 microscope (Invitrogen). 19
Enteroid formation efficiency. Single cells were encapsulated as above and cultured in EM for 20 four days (Matrigel) or six days (synthetic matrix) before imaging at 10X magnification using an 21 EVOS M500 microscope. Sixty BF images, spanning the entire thickness of the matrix, were 22 collected from the center of the droplet. This is approximately 1/3 of the total droplet volume. The 23 image z-stacks were processed in Fiji using the time lapse Gaussian-based stacker focuser plugin 24 to create a single image with all enteroids in focus. The number of enteroids with a clear lumen 25 and the number of single cells were manually counted using the cell counter feature in Fiji 15 . We 26 also observed and counted few cell clumps that did not show a clear lumen but were bigger than 27 single cells. Enteroid formation efficiency was calculated as the percentage of enteroids with a 28 clear lumen relative to the total number of enteroids, single cells, and cell clumps, counted in each 29
droplet. 30
Live/dead imaging. Single cells were encapsulated as before for six days (intestinal) or eight days 1 (endometrial) before the addition of Calcein AM (2 mM) and Ethidium homodimer-1 (2 mM) for 2 20 minutes. Images were captured using either a ZEISS confocal Laser Scanning Microscope 3 (LSM 880) equipped with temperature (37 °C), humidity, and CO2 (5%) controls orr an EVOS 4 M500 (Invitrogen) microscope (no incubation). A 1.6 mm by 1.6 mm area and ~800 µm thick 5 section of either Matrigel or the synthetic ECM were imaged with the confocal. With the EVOS, 6
we captured the center of the droplet, which is ~ 1/3 of the total matrix area. The final images were 7 processed using the ZEN blue ZEISS companion software or Fiji 15 . For time-course live/dead 8 imaging analysis, 60 z-stacks images were taken the day of seeding (day 0) then every two days 9 for up to ten days, using the EVOS M500 microscope and processed as above. 10
Continues live imaging. Single cells were encapsulated and plated on 96-well optical plates as 11 described before, then cultured in OEM. Bright field images were captured using a ZEISS confocal 12
Laser Scanning Microscope (LSM 880) equipped with a wide-field camera and temperature (37 13 °C), humidity, and CO2 (5%) controls. A single plane of four-day old enteroids were imaged every 14 5 minutes for 48 hours. The final videos were prepared using Fiji using frame interpolation to 15 smooth the video 15 . To capture individual cells forming enteroids, the entire thickness of the 16 matrices was imaged the day after encapsulation and then the everyday for up to six days. The 17 stack of images was processed in Fiji as described in enteroid formation efficiency 15 . 18
Cell proliferation. To determine if cells from enteroids in the synthetic ECM retain their 19 proliferative capacity, we collected six-day old enteroids from within the synthetic ECM using 20 SrtA treatment 16 , then digested them with trypsin to generate a single cell suspension. Cells (500 21 cells/µl, 5 µl droplets, 48 droplets total) were embedded in Matrigel or the synthetic ECM and 22 cultured in EM for six days. After six days, the matrix droplets were pooled and processed as 23 follows; enteroids in Matrigel were released using CRS whereas enteroids in the synthetic ECM 24 were released using SrtA treatment. Enteroids in both conditions were then digested with trypsin 25 to get the total number of cells recovered from the pooled enteroids, from each matrix condition. 26
The fold increase in cell number was calculated as the ratio of total number of cells obtained from 27 enteroids after six days of culture divided by the total number of cells used at the beginning of the 28 experiment. The cells recovered from enteroids in Matrigel were discarded. The cells recovered 29 from enteroids in the synthetic ECM were used to set up a new experiment (first passage, 500 30 cells/µl, 5 µl droplets, 48 droplets total) in new synthetic ECM or Matrigel. At the end of six days, 31 the fold increase in cell number was determined as before. This process was repeated three 1 consecutive passages using two human duodenal donors. In parallel experiments, using the same 2 pool of cells, we measured the enteroid diameter of the three consecutive passagesas previously 3 described 14 . 4
Quantitative real time PCR (qPCR). Four-day old enteroids grown in Matrigel were used to 5 generate a single-cell suspension as described above. Single cells (500 cells/µL) were encapsulated 6 in Matrigel or the synthetic ECM, then cultured in EM. After six days, intact enteroids were 7 released from Matrigel and the synthetic ECM, as described before. Intact enteroids were pelleted, 8 resuspended in TRIzol reagent (ThermoFisher Scientific, 15596026), and then stored at -80 °C 9 until processing. From the initial cell suspension, we reserved 500,000 cells at -80 °C in TRIzol. 10
This single-cell population was used to determine the gene expression of the "initial cell 11 population". RNA was extracted from enteroids (or cells) using the Directzol RNA Mini-Prep kit 12 (Zymo Research) per the manufacturer's protocols with the inclusion of an on-column DNase step 13 using the PureLink DNase Set (Thermofisher Scientific, 12185010). cDNA was synthesized from 14 ~ 1 µg of total RNA using the High-Capacity RNA-to-cDNA Kit (Thermofisher Scientific, 15 4387406) per manufacturer's protocols. TaqMan Fast Advanced Master Mix (Thermofisher 16 Scientific, 4444557) was used in congruence with the cell-specific probes for qPCR described in 17 the supplementary Table 2 . Gene expression was determined using the StepOnePlus real-time PCR 18 system (Applied Biosystems) and calculated using the DDCt method in GraphPad Prism. Gene 19 expression was first normalized using the housekeeping GAPDH gene in each sample, then the 20 relative fold change in gene expression, in Matrigel or the synthetic ECM, was calculated against 21 the gene expression of the "initial cell population" that was set to 1. The experiment was repeated 22 three times with two duodenal donors. 23
Histological processing and immunostaining. Mouse intestinal organoids were fixed in while 24 still in the gel (3D), then paraffin-embedded and sectioned in the Histology Center at the Koch 25 Institute at MIT. 5-micron tissue sections were hematoxylin and eosin stained using standard 26
procedures. 27
Immunostaining and EdU labeling. Organoids and enteroids were processed in two formats: in 28 3D (embedded within the synthetic ECM or Matrigel) and in suspension (free floating) after being 29 released from the matrices. Six-day old enteroids in 3D were treated with EdU (5-ethynyl-2'-30 deoxyuridine, 20 µM) for 3 hr (Alexa Flour 488 Click-it EDU, Thermo Fisher) prior fixation 31 overnight with formalin (10%, VWR) at 4 °C. Eight-day old endometrial organoids in 3D were 1 treated with EdU for 6 hr prior to overnight fixation. Eight-day old colon organoids were treated 2 with EdU for 6 hr, then released from the matrices and fixed as free-floating organoids for 30 min 3 at RT. After fixation, organoids and enteroids in 3D were permeabilized with 0.1% triton X-100 4 in PBS overnight followed by blocking (4% BSA/0.5% Tween 20 in 1XPBS or 4% Donkey 5 serum/0.5% Tween 20 in 1X PBS) overnight at 4°C with 200 rpm shaking. Free-floating organoids 6 were permeabilized for 1h at RT incubated in a tube rotator set at 30 rpm, followed by 3 hr of 7 blocking. To identify proliferative cells, the Alexa Flour 488 was click-reacted according to the 8 manufacturer instruction. Immunostaining for cell-specific markers was done using the following 9 13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31 
